Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report
The legal status of hemp has been under intense scrutiny ever since the 2018 Farm Bill federally legalized hemp (defined as cannabis with less than 0.3% delta-9 THC). However, as America’s hemp and cannabis industries mature, unforeseen legal ambiguities, regulatory gaps, and enforcement challenges have emerged. In August 2025, the Congressional Research Service (CRS) published a pivotal report outlining four vital considerations for Congress as the nation seeks to recalibrate the federal hemp legal framework. Stakeholders across the sector are closely monitoring these CRS hemp policy recommendations as Congress debates revisions to the Farm Bill and future regulation of hemp-derived cannabinoids.
The 2018 Farm Bill (source) distinguished hemp from marijuana by THC concentration, catalyzing a surge in the production of a wide array of cannabinoids, including those with intoxicating potential like delta-8 and delta-10 THC. However, this broad definition created regulatory ambiguity, conflicting state policies, and new consumer protection concerns. Recent federal and state court decisions, along with inconsistent enforcement by agencies like the DEA and FDA, have left both hemp businesses and regulators searching for clarity (CRS PDF, Aug 2025).
With the 2025 Farm Bill on the horizon and momentum building in Congress to address loopholes and public health risks, the CRS’s four core considerations merit close attention from business leaders, compliance officers, policymakers, and advocates alike.
Definition Ambiguity: The CRS points out that the 2018 Farm Bill uses total delta-9 THC content (not the total of all THC analogues), causing legal confusion, particularly as products with intoxicating cannabinoids—like delta-8 THC—proliferate. Courts have interpreted the law inconsistently, and some states enacted their own restrictions on synthetic and semi-synthetic cannabinoids.
CRS Recommendation: Congress should consider whether to revise the federal definition of hemp, possibly by:
Implications:
For background, see the Cannabis Business Times summary.
Enforcement Gaps: Currently, enforcement is split among multiple agencies (principally the DEA, USDA, and FDA). This patchwork oversight leads to uncertainty and hinders uniform compliance.
CRS Recommendation: Congress should consider:
Implications:
Synthetic Sources: The rise of synthetic and semi-synthetic cannabinoids—particularly intoxicating hemp derivatives—has prompted enforcement actions and legislative debates nationwide. The Farm Bill’s language leaves open questions about which compounds are actually legal, especially those produced from chemical reactions, not from the cannabis plant naturally.
CRS Recommendation: Congress could:
Implications:
Preemption and Patchwork Policy: States have taken widely divergent paths—some banning all intoxicating hemp products, others encouraging their sale. State-federal overlaps have sparked legal disputes and confusion, particularly regarding transportation and sale of hemp goods across state lines.
CRS Recommendation: Congress should consider whether to:
Implications:
Regardless of the Farm Bill’s revision schedule, cannabis compliance, testing, labeling, and tracking obligations remain central for licensed hemp businesses:
For updated licensing requirements, consult your state’s department of agriculture or cannabis regulatory agency, and refer to compliance resources at CannabisRegulations.ai.
Industry participants should review their compliance systems, update staff training, and revise SOPs as federal and state priorities shift.
The CRS hemp policy recommendations offer a historic opportunity to resolve the regulatory ambiguity that has hindered hemp market stability and consumer safety since 2018. Congress’s next steps will shape the compliance landscape—affecting everything from seed genetics to end-product retailing.
Key Takeaways:
For comprehensive, up-to-date support on licensing, regulations, and compliance—including tailored alerts as new federal and state rules are adopted—explore CannabisRegulations.ai today and safeguard your business’s future in a rapidly evolving landscape.